Heron Therapeutics
HRTX
#8228
Rank
NZ$0.42 B
Marketcap
NZ$2.30
Share price
-1.48%
Change (1 day)
-23.00%
Change (1 year)

Heron Therapeutics (HRTX) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.24 Billion

According to Heron Therapeutics's latest financial reports the company's total debt is NZ$0.24 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Heron Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.31 B10.97%
2023-12-31NZ$0.28 B14.52%
2022-12-31NZ$0.24 B6.22%
2021-12-31NZ$0.23 B584.59%
2020-12-31NZ$34.1 M16.07%
2019-12-31NZ$29.38 M330.97%
2018-12-31NZ$6.81 M-83.12%
2017-12-31NZ$40.38 M-47.13%
2016-12-31NZ$76.38 M2252.79%
2015-12-31NZ$3.24 M59.18%
2014-12-31NZ$2.03 M63.51%
2013-12-31NZ$1.24 M108.56%
2012-12-31NZ$0.59 M353.18%
2011-12-31NZ$0.13 M
1999-12-31NZ$6.31 M7.35%
1998-12-31NZ$5.88 M-39.04%
1997-12-31NZ$9.65 M-3.97%
1996-12-31NZ$10.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Alkermes
ALKS
NZ$0.12 B-49.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
NZ$0.73 B 202.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.15 B-34.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.77 B 221.12%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
NZ$56.34 M-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA